Fisher Asset Management
ORKA

Fisher Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Fisher Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46M Buy
+67,874
New +$4.52M ﹤0.01% 450

Other funds holding ORKA

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fisher Asset Management's ORKA Position: Q2 2026 in Review

Fisher Asset Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 67,874 shares worth $6.46M. The stake represents ﹤0.01% of the portfolio and ranks #450 among its holdings.

49 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Fisher Asset Management held 67,874 shares of Oruka Therapeutics worth $6.46M as of Q2 2026.
  • Oruka Therapeutics was a new Fisher Asset Management position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #450 holding.
  • 49 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.